Insmed Inc. buy Guggenheim
Start price
25.02.25
/
50%
€74.00
Target price
25.02.26
€96.10
Performance (%)
68.92%
End price
26.02.26
€125.00
Summary
This prediction ended on 26.02.26 with a price of €125.00. With a performance of 68.92% the BUY prediction by Guggenheim was a big success. Guggenheim has a follow-up prediction for Insmed Inc. where he still thinks Insmed Inc. is a Buy. Guggenheim has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Insmed Inc. | -8.290% | -8.290% | 91.048% |
| iShares Core DAX® | 3,59 % | 3,93 % | 15,38 % |
| iShares Nasdaq 100 | 5,81 % | 5,52 % | 41,46 % |
| iShares Nikkei 225® | 4,08 % | 8,46 % | 48,95 % |
| iShares S&P 500 | 4,14 % | 4,04 % | 31,59 % |
Comments by Guggenheim for this prediction
In the thread Insmed Inc. diskutieren
Insmed Incorporated (NASDAQ: INSM) had its "buy" rating re-affirmed by analysts at Guggenheim. They now have a $101.00 price target on the stock.
Ratings data for INSM provided by MarketBeat
In the thread Trading Insmed Inc.
Die von Guggenheim gewählte maximale Laufzeit wurde überschritten